Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010

Clinical Infectious Diseases

Volumn 59, Issue 7, 2014, Pages 976-981

  Spradling, Philip R ^a   Tong, Xin ^a   Rupp, Loralee B ^b   Moorman, Anne C ^a   Lu, Mei ^b   Teshale, Eyasu H ^a   Gordon, Stuart C ^b   Vijayadeva, Vinutha ^c   Boscarino, Joseph A ^d   Schmidt, Mark A ^c   Holmberg, Scott D ^a   Nerenz, David R ^b   Lamerato, Lois ^b   Akkerman, Nonna ^b   Oja Tebbe, Nancy ^b   Cogan, Chad M ^b   Larkin, Dana ^b   Daar, Zahra S ^d   Leader, Joe B ^d   Smith, Robert E ^d   Sylva, Kelly E ^c   Parker, John V ^c   Schmidt, Mark M ^c   Donald, Judy L ^c   Keast, Erin M ^c   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c KAISER PERMANENTE   (United States)

^d GEISINGER HEALTH SYSTEM   (United States)

Author keywords

Diagnosis; Hepatitis C virus; Infection; Testing

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS RNA TEST; HOUSEHOLD INCOME; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MULTICENTER STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; AGED; BLOOD; MIDDLE AGED; UTILIZATION; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA, VIRAL; YOUNG ADULT;

EID: 84926463417     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu509     Document Type: Article

References (16)

1. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014; 160:293-300.
2. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998; 47:1-54.
3. Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003; 52:1-16.
4. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61:1-18.
5. Centers for Disease Control and Prevention. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 2013; 62:1-4.
6. American Association for the Study of Liver Diseases/Infectious Disease Society of America. Recommendations for testing, managing, and treating hepatitis C. Available at: http://hcvguidelines.org/full-report-view. Accessed 3 March 2014.
7. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med 2013; 368:1859-61.
8. Centers for Disease Control and Prevention. Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2001. MMWR Morb Mortal Wkly Rep 2013; 62:357-61.
9. Spradling PR, Rupp L, Moorman AC, et al.; CHeCS Investigators. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis 2012; 55:1047-55.
10. Moorman A, Gordon S, Rupp L, et al.; CHeCS Investigators. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study. Clin Infect Dis 2013; 56:40-50.
11. McGibbon E, Bornschlegel K, Balter S. Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients. Am J Med 2013; 126:718-22.
12. Rongey CA, Kanwal F, Hoang T, Gifford AL, Asch SM. Viral RNA testing in hepatitis C antibody-positive veterans. Am J Prev Med 2009; 36:235-8.
13. Department of Veterans Affairs. Reflex confirmatory testing for chronic hepatitis C virus infection. VHA Directive 2009-063. 2009.
14. New York City Hepatitis C Task Force. Hep C RNA reflex tests now available from commercial labs. Available at: http://nychepbc.org/hep-creflex-tests-now-available-from-commercial-labs/#sthash.tWuLw25k. dpbs. Accessed 6 March 2014.
15. Abbott Laboratories. Abbott RealTime HCV. Available at: http://www. abbottmolecular.com/static/cms-workspace/pdfs/US/Abbott-RealTime- HCV-PI.pdf. Accessed 3 April 2014.
16. COBAS® AmpliPrep/COBAS® TaqMan® HCV Qualitative and Quantitative Tests, v2.0. Available at: http://molecular.roche.com/assays/Pages/ COBASAmpliPrepCOBASTaqManHCVTest-2.aspx. Accessed 20 March 2014.